Natco Pharma Limited
NATCOPHARM · NSE · ₹822 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Natco Pharma Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue fell 44.7%; Net profit was ₹206.50 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹735 cr | -44.7% | Net profit: ₹206 cr | -57.0% | 28.1% | Company filing source |
| Mar 2026 | Revenue: ₹739 cr | -39.5% | Net profit: ₹269 cr | -33.7% | 36.4% | Company filing source |
| Dec 2025 | Revenue: ₹647 cr | — | Net profit: ₹151 cr | — | 23.4% | Company filing source |
| Sep 2025 | Revenue: ₹1,363 cr | — | Net profit: ₹518 cr | — | 38.0% | Company filing source |
| Jun 2025 | Revenue: ₹1,329 cr | -2.5% | Net profit: ₹480 cr | -28.2% | 36.1% | Company filing source |
| Mar 2025 | Revenue: ₹1,221 cr | — | Net profit: ₹406 cr | — | 33.3% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
V C NANNAPANENI 15.7%TIME CAP PHARMA LABS PRIVATE LIMITED 9.6%VENKATA SATYA SWATHI KANTAMANI 8.9%NATSOFT INFORMATION SYSTEMS PVT LTD 8.8%BELGRAVE INVESTMENT FUND 2.3%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
30 Sep 2026 · document
- Shareholders meeting. Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of 43rd Annual General Meeting held on September 30, 2026. Furth…
30 Sep 2026 · document
- Shareholders meeting. Natco Pharma Limited has informed the Exchange regarding Proceedings of 43rd Annual General Meeting held on September 30, 2026…
30 Sep 2026 · document
- Committee Meeting Updates. Natco Pharma Limited has informed the Exchange regarding Outcome of Fund Raising Committee Meeting approving the Letter of Offer for …
28 Sep 2026 · document
- Natco Pharma Limited has informed the Exchange regarding a press release dated September 28, 2026, titled "Press Release under SEBI (LODR) Regulations, 2015".…
28 Sep 2026 · document
- Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Record date for Rights Issue…
26 Sep 2026 · document
- Record Date. Natco Pharma Limited has informed the Exchange that Record date for the purpose of Rights is 01-Oct-2026.…
25 Sep 2026 · document
- Issue of Securities. Natco Pharma Limited has informed the Exchange about issue of Securities on Rights Basis…
25 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time